Tianyi Wang

1.7k total citations
27 papers, 1.3k citations indexed

About

Tianyi Wang is a scholar working on Epidemiology, Immunology and Molecular Biology. According to data from OpenAlex, Tianyi Wang has authored 27 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 6 papers in Immunology and 5 papers in Molecular Biology. Recurrent topics in Tianyi Wang's work include Hepatitis B Virus Studies (6 papers), Hepatitis C virus research (5 papers) and interferon and immune responses (3 papers). Tianyi Wang is often cited by papers focused on Hepatitis B Virus Studies (6 papers), Hepatitis C virus research (5 papers) and interferon and immune responses (3 papers). Tianyi Wang collaborates with scholars based in United States, China and United Kingdom. Tianyi Wang's co-authors include Carolyn B. Coyne, Wei Yang, Shufeng Liu, Le Shen, Jerrold R. Turner, Amitava Mukherjee, Stefanie A. Morosky, Xiuying Liu, Elizabeth Delorme‐Axford and M. Steven Oberste and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The EMBO Journal.

In The Last Decade

Tianyi Wang

25 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tianyi Wang United States 16 420 419 395 369 177 27 1.3k
Shih‐Yen Lo Taiwan 21 466 1.1× 562 1.3× 707 1.8× 195 0.5× 122 0.7× 53 1.5k
Dahlene N. Fusco United States 21 1.2k 2.8× 416 1.0× 386 1.0× 290 0.8× 80 0.5× 42 2.0k
Helen J. Harris United Kingdom 19 326 0.8× 876 2.1× 990 2.5× 136 0.4× 36 0.2× 27 1.6k
Bruno Baron France 22 669 1.6× 250 0.6× 163 0.4× 217 0.6× 84 0.5× 48 1.5k
Matthew T. Miller United States 16 868 2.1× 276 0.7× 220 0.6× 473 1.3× 129 0.7× 21 1.5k
Selena M. Sagan Canada 22 850 2.0× 394 0.9× 385 1.0× 166 0.4× 127 0.7× 61 1.8k
Colette Jolivet‐Reynaud France 21 490 1.2× 124 0.3× 86 0.2× 333 0.9× 81 0.5× 38 1.4k
Jin‐Hwan Han United States 14 236 0.6× 676 1.6× 618 1.6× 781 2.1× 10 0.1× 27 1.7k
Gilles Merlin France 26 803 1.9× 528 1.3× 54 0.1× 1.2k 3.2× 65 0.4× 47 2.3k
Gregory P. McNerney United States 11 462 1.1× 221 0.5× 61 0.2× 233 0.6× 105 0.6× 16 1.3k

Countries citing papers authored by Tianyi Wang

Since Specialization
Citations

This map shows the geographic impact of Tianyi Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tianyi Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tianyi Wang more than expected).

Fields of papers citing papers by Tianyi Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tianyi Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tianyi Wang. The network helps show where Tianyi Wang may publish in the future.

Co-authorship network of co-authors of Tianyi Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Tianyi Wang. A scholar is included among the top collaborators of Tianyi Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tianyi Wang. Tianyi Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Yandi, Jiaoyang Cai, Tianyi Wang, et al.. (2024). Glycoprotein 350-targeted chimeric antigen receptor T-cell therapy for nonneoplastic chronic active Epstein-Barr virus infection: a case report. Translational Pediatrics. 13(12). 2305–2310.
2.
Dai, Bingqian, Di Wu, Seyed Armin Razavi, et al.. (2023). Electric field manipulation of spin chirality and skyrmion dynamic. Science Advances. 9(7). eade6836–eade6836. 34 indexed citations
3.
Wang, Jiashu, Tianyi Wang, Mykhaylo Ozerov, et al.. (2023). Energy gap of topological surface states in proximity to a magnetic insulator. Communications Physics. 6(1). 6 indexed citations
4.
Ghosh, Atreyie, Sena Yang, Yanan Dai, et al.. (2021). A topological lattice of plasmonic merons. Applied Physics Reviews. 8(4). 49 indexed citations
5.
Anderson, D. Mark, Daniel I. Rees, & Tianyi Wang. (2020). The phenomenon of summer diarrhea and its waning, 1910-1930. Explorations in Economic History. 78. 101341–101341. 11 indexed citations
6.
Zhang, Chao, et al.. (2017). Quasi-two-dimensional vortex–glass transition and the critical current density in TiO epitaxial thin films. Superconductor Science and Technology. 31(1). 15016–15016. 8 indexed citations
7.
Niu, Jixiao, Yuling Shi, Jingyan Xue, et al.. (2013). USP10 inhibits genotoxic NF‐κB activation by MCPIP1‐facilitated deubiquitination of NEMO. The EMBO Journal. 32(24). 3206–3219. 89 indexed citations
8.
Liu, Shufeng, Kevin D. McCormick, Wentao Zhao, et al.. (2012). Human apolipoprotein E peptides inhibit hepatitis C virus entry by blocking virus binding. Hepatology. 56(2). 484–491. 57 indexed citations
9.
Si, Youhui, Shufeng Liu, Xiuying Liu, et al.. (2012). A human claudin-1–derived peptide inhibits hepatitis C virus entry. Hepatology. 56(2). 507–515. 47 indexed citations
10.
Biswas, Nabanita, Tianyi Wang, Ming Ding, et al.. (2011). ADAR1 is a novel multi targeted anti-HIV-1 cellular protein. Virology. 422(2). 265–277. 34 indexed citations
11.
Mukherjee, Amitava, Stefanie A. Morosky, Elizabeth Delorme‐Axford, et al.. (2011). The Coxsackievirus B 3Cpro Protease Cleaves MAVS and TRIF to Attenuate Host Type I Interferon and Apoptotic Signaling. PLoS Pathogens. 7(3). e1001311–e1001311. 253 indexed citations
12.
Si, Youhui, Xiuying Liu, Min Cheng, et al.. (2011). Growth Differentiation Factor 15 Is Induced by Hepatitis C Virus Infection and Regulates Hepatocellular Carcinoma-Related Genes. PLoS ONE. 6(5). e19967–e19967. 45 indexed citations
13.
Biswas, Nabanita, Shufeng Liu, Tapani Ronni, et al.. (2011). The Ubiquitin-Like Protein PLIC-1 or Ubiquilin 1 Inhibits TLR3-Trif Signaling. PLoS ONE. 6(6). e21153–e21153. 17 indexed citations
14.
Liu, Shufeng, Wei Yang, Weiqun Liu, et al.. (2010). The second extracellular loop dictates Occludin-mediated HCV entry. Virology. 407(1). 160–170. 39 indexed citations
15.
Liu, Xiuying, Tianyi Wang, Takaji Wakita, & Wei Yang. (2009). Systematic identification of microRNA and messenger RNA profiles in hepatitis C virus-infected human hepatoma cells. Virology. 398(1). 57–67. 104 indexed citations
16.
Chang, Kyung-Soo, Tianyi Wang, & Guangxiang Luo. (2009). Proteomics Study of the Hepatitis C Virus Replication Complex. Methods in molecular biology. 510. 185–193. 3 indexed citations
17.
Mukherjee, Amitava, Stefanie A. Morosky, Le Shen, et al.. (2009). Retinoic Acid-induced Gene-1 (RIG-I) Associates with the Actin Cytoskeleton via Caspase Activation and Recruitment Domain-dependent Interactions. Journal of Biological Chemistry. 284(10). 6486–6494. 46 indexed citations
18.
19.
Yang, Wei, Chao Qiu, Nabanita Biswas, et al.. (2008). Correlation of the Tight Junction-like Distribution of Claudin-1 to the Cellular Tropism of Hepatitis C Virus. Journal of Biological Chemistry. 283(13). 8643–8653. 86 indexed citations
20.
Liu, Shufeng, Wei Yang, Le Shen, et al.. (2008). Tight Junction Proteins Claudin-1 and Occludin Control Hepatitis C Virus Entry and Are Downregulated during Infection To Prevent Superinfection. Journal of Virology. 83(4). 2011–2014. 260 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026